Results 171 to 180 of about 68,398 (251)

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

Histopathology, Volume 89, Issue 2, Page 372-382, August 2026.
Glomerular plasmalemma vesicle‐associated protein‐1 (PV‐1/PLVAP) identifies dynamic endothelial remodelling in chronic active antibody‐mediated rejection (caABMR), complementing glomerular C4d, which reflects a static footprint of complement activation. Combined assessment of PV‐1 and C4d captures complementary dimensions of microvascular pathology and
Yuto Igarashi, Mayu Shimokawa, Kunio Kawanishi, Toshihito Hirai, Hiroshi Seino, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi   +7 more
wiley   +1 more source

Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: Case reports. [PDF]

Medicine (Baltimore), 2021
Deveci B, Saba R.
europepmc   +1 more source

Anti-CD20 Monoclonal Antibody SCT400 [PDF]

, 2020
openaire   +1 more source

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis. [PDF]

Ther Adv Neurol Disord
Selmaj K, Gold R, Selmaj I, Mycko MP.
europepmc   +1 more source

Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration. [PDF]

Life (Basel), 2022
Kawanabe R, Yoshizaki A, Matsuda KM, Kotani H, Hisamoto T, Norimatsu Y, Kuzumi A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Sato S.   +10 more
europepmc   +1 more source

Anti-CD20 Monoclonal Antibody PRO131921 [PDF]

, 2020
openaire   +1 more source

Efficacy and safety of anti-CD20 monoclonal antibody therapy for autoimmune nodopathies: a systematic review and meta-analysis. [PDF]

Front Neurol
Tao Z, Jiang Y, Gui Q, Ma J.
europepmc   +1 more source

Combination Therapy With Ensitrelvir and Remdesivir Versus Antiviral Monotherapy in Patients Receiving Anti-CD20 Monoclonal Antibody Therapy: A Retrospective Cohort Study. [PDF]

Cureus
Takano T, Aiba H, Takemura H, Kunishima H.   +3 more
europepmc   +1 more source

Chemotherapy and anti-CD20 monoclonal antibody impact on SARS-CoV-2 nucleic acid amplification tests in hematologic malignancies: a retrospective study. [PDF]

BMC Infect Dis
Kinoshita K, Maruyama W, Miyake H, Sada RM.   +3 more
europepmc   +1 more source

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas. [PDF]

Haematologica, 2022
Candon S, Lemee V, Leveque E, Etancelin P, Paquin C, Carette M, Contentin N, Bobee V, Alani M, Cardinael N, Lepretre S, Camus V, Bouclet F, Boulet E, Menard AL, Lanic H, Stamatoullas A, Lemasle E, Pepin LF, Richard D, Dubois S, Tilly H, Dalleac A, Plantier JC, Etienne M, Jardin F.   +25 more
europepmc   +1 more source